Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM1FB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,372
Award facts
- Contract value 100% obligated
- $12,372.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors with a ceiling value of $12,372.49 under firm fixed pricing. The award, issued on December 23, 2025, with an ultimate completion date of December 24, 2025, represents a non-competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive vehicle for pharmaceutical and medical supply distribution to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to federal agencies, particularly the Defense Health Agency and military healthcare systems. The company's extensive portfolio includes specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains. As a prime vendor under the DLA Troop Support Medical contract, AmerisourceBergen has demonstrated consistent capability to fulfill federal medical supply requirements through open competition, with delivery orders ranging significantly in value and supporting healthcare initiatives worldwide.
Quick answers
Who was awarded contract SPE2DR26FM1FB?
SPE2DR26FM1FB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FM1FB worth?
The government has obligated $12,372 on SPE2DR26FM1FB.
Is contract SPE2DR26FM1FB an order under another contract?
Yes. SPE2DR26FM1FB is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM1FB competed?
The extent of competition for SPE2DR26FM1FB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award